David Melnick
-
- Antibiotic Use and Resistance 5
- Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria 12
- Pharmacology top 1%
- Antibiotics Pharmacokinetics and Efficacy 20
- Infectious Diseases top 2%
- Antimicrobial Resistance in Staphylococcus 5
- Tuberculosis Research and Epidemiology 5
- Clinical Biochemistry top 5%
-
- Pneumonia and Respiratory Infections 12
-
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms 6
-
- S100 Proteins and Annexins 5
- Co-authors
- Tova MeshulamAmy N. SchillingVincent H. TamR SullivanHarry L. MalechElizabeth A. CoyleShádi NeshatKeith Poole
- Journals
- Antimicrobial Agents and Chemotherapy (13 papers)Open Forum Infectious Diseases (8 papers)The Journal of Immunology (6 papers)
- Partner nations
- United StatesUnited KingdomChina
In The Last Decade
David Melnick
53 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 109
- Applied Microbiology and Biotechnology 254
- Molecular Medicine 581
- Pharmacology 695
- Infectious Diseases 569
- Clinical Biochemistry 142
Countries citing papers authored by David Melnick
This map shows the geographic impact of David Melnick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Melnick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Melnick more than expected).
Fields of papers citing papers by David Melnick
This network shows the impact of papers produced by David Melnick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Melnick. The network helps show where David Melnick may publish in the future.
Co-authorship network
The 25 scholars most cited alongside David Melnick, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 6 | |
| 2 | 2024 | 3 | |
| 3 | 2023 | 5 | |
| 4 | 2023 | 1 | |
| 5 | 2019 | 39 | |
| 6 | 2017 | 3 | |
| 7 | 2015 | 21 | |
| 8 | 2014 | 62 | |
| 9 | 2013 | 74 | |
| 10 | 2009 | 6 | |
| 11 | 2006 | 16 | |
| 12 | 2005 | 32 | |
| 13 | 2005 | 71 | |
| 14 | 2004 | 10 | |
| 15 | 2000 | 5 | |
| 16 | 1992 | 67 | |
| 17 | 1992 | 40 | |
| 18 | 1988 | 25 | |
| 19 | 1988 | 98 | |
| 20 | 1988 | 26 |
About David Melnick
David Melnick is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine, Pharmacology, Critical Care and Intensive Care Medicine and Infectious Diseases, having authored 55 papers that have together received 2.0k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (20 papers), Pneumonia and Respiratory Infections (12 papers), Antibiotic Resistance in Bacteria (12 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (6 papers), Antimicrobial Resistance in Staphylococcus (5 papers), S100 Proteins and Annexins (5 papers), Tuberculosis Research and Epidemiology (5 papers) and Antibiotic Use and Resistance (5 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (254 citations), Molecular Medicine (581 citations), Pharmacology (695 citations), Infectious Diseases (569 citations) and Clinical Biochemistry (142 citations). David Melnick has collaborated with scholars based in United States, United Kingdom and China. Frequent co-authors include Tova Meshulam, Amy N. Schilling, Vincent H. Tam, R Sullivan, Harry L. Malech, Elizabeth A. Coyle, Shádi Neshat, Keith Poole, Richard D. Diamond and Thomas P. Lodise. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Open Forum Infectious Diseases, The Journal of Immunology, Journal of Biological Chemistry and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.